SAN ANTONIO – The first round of people taking part in a trial for the COVID-19 vaccine in South Texas received a dose on Thursday.
The Pfizer double-blind study is different from the Modern vaccine test, which is due to begin on Friday after being delayed for several days.
“I can’t think of a more important clinical trial to participate in than this, because it’s the biggest threat to my health,” said Dr. Stephen Davis, one of the first participants in the Pfizer study. “I am a big believer in clinical trials. We, from our own practice, do clinical trials. And if it weren̵
Although the trial was a double-blind study and Davis was unsure whether he, his wife or son would receive the actual vaccine or placebo, he said he was glad he was given the opportunity to participate.
“They want to test people over 65. My wife and I are over 65. They want to test people who are directly involved in healthcare. “My son and I, who work in my office, are directly involved in healthcare,” Davis said.
Texas College Biotechnology Facility Tapped for Mass Production of Potential COVID-19 Vaccine
To participate in the Pfizer trial, you must be 18 years of age or older and call the clinical trials of Texas, the laboratory that hosts the study, to be examined.
“We want to know and try to determine … If they have a disease or condition, is it under control? We want to know what drugs are being used, “said CTT CEO Kay Skrogins.
Like other studies, the researchers assured participants that they could not become infected with the coronavirus by receiving the Pfizer vaccine, which is not live.
“It’s a part of the virus. So when the virus is applied, it will cause hope for an immune response, ”said Skrogins.
If the test is successful and everything goes according to plan, the vaccine against Pfizer may be available to the public as early as next year.
United British scientists to immunize hundreds with coronavirus vaccine
Clinical trials in Texas are aiming to screen thousands more to participate in the two-year Pfizer trial, as well as at least two other trials for COVID-19 vaccines that are expected to begin in the next few months.
For more information call 210-949-0122 or click here.
Copyright 2020 by KSAT – All rights reserved.